Freyja Healthcare LLC

Freyja Healthcare develops surgical devices focused on minimally invasive procedures, with initial concentration on women's health. The company's flagship product, VereSee™, is the first 2mm laparoscopic entry device with integrated high-definition video for direct visualization during abdominal access. VereSee™ eliminates blind entry during laparoscopic procedures, enabling surgeons to visualize the insertion site in real time, thereby improving surgical accuracy and efficiency. The device received FDA 510(k) clearance in May 2024. Freyja Healthcare is positioned to expand beyond women's health into broader surgical applications. The company emphasizes precision, innovation, and control in surgical tool design, addressing gaps in a market segment historically characterized by limited innovation.